QQ客服 官方微博 反馈留言

浏览/检索结果: 共5条，第1-5条 帮助 已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Cycloserine for treatment of multidrug-resistant tuberculosis: a retrospective cohort study in China 期刊论文 INFECTION AND DRUG RESISTANCE, 2019, 卷号: 12 作者:  He, Guiqing;  Sun, Feng;  Chen, Xinchang;  Zhang, Wenhong;  Wang, Xiaomeng 收藏  |  浏览/下载：32/0  |  提交时间：2019/12/05 cycloserine  multidrug-resistant tuberculosis  efficacy  safety  extensively drug-resistant tuberculosis  treatment outcome   Clofazimine for Treatment of Extensively Drug-Resistant Pulmonary Tuberculosis in China 期刊论文 2018, 卷号: 62, 期号: 4 作者:  Wang, Qingfeng;  Pang, Yu;  Jing, Wei;  Liu, Yufeng;  Wang, Na 收藏  |  浏览/下载：10/0  |  提交时间：2020/01/03 clofazimine  extensively drug-resistant tuberculosis  clinical outcome  efficacy  safety   Efflux Pump Gene Expression in Multidrug-Resistant Mycobacterium tuberculosis Clinical Isolates 期刊论文 PLOS ONE, 2015, 卷号: 10, 期号: 2, 页码: e0119013 作者:  Li, Guilian;  Zhang, Jingrui;  Guo, Qian;  Jiang, Yi;  Wei, Jianhao 收藏  |  浏览/下载：7/0  |  提交时间：2019/12/27 Mycobacterium tuberculosis,Reserpine,Tuberculosis diagnosis and management,Deletion mutation,Gene expression,Extensively drug-resistant tuberculosis,DNA sequence analysis,Mutation   Molecular characterisation of extensively drug-resistant Mycobacterium tuberculosis isolates in China 期刊论文 International Journal of Antimicrobial Agents, 2015, 卷号: 45, 期号: 2, 页码: 137-143 作者:  Zhao, Li-li;  Sun, Qing;  Zeng, Chun-yan;  Chen, Yan;  Zhao, Bing 收藏  |  浏览/下载：1/0  |  提交时间：2019/12/27 Extensively drug-resistant tuberculosis  Molecular characterisation  Genotype  Resistance-conferring mutations   Extensively drug-resistant tuberculosis at a tuberculosis specialist hospital in Shanghai, China: Clinical characteristics and treatment outcomes 期刊论文 SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2011, 卷号: 43, 期号: 4 作者:  Tang Shenjie;  Zhang Qing;  Yu Jinming;  Liu Yidian;  Sha Wei 收藏  |  浏览/下载：1/0  |  提交时间：2019/12/19 Tuberculosis  extensively drug-resistant  drug susceptibility testing  characteristics  outcomes